"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
(Generic versions may still be available.)
Careful observation should be made for severe cholinergic reactions in the hyperreactive individual. The myasthenic patient in crisis who is being tested with Enlon (edrophonium injection) ® should be observed for bradycardia or cardiac standstill and cholinergic reactions if an overdose is given.
The following reactions common to anticholinesterase agents may occur, although not all of these reactions have been reported with the administration of Enlon (edrophonium injection) ®, probably because of its short duration of action and limited indications:
|CNS:||Convulsions, dysarthria, dysphonia, dysphagia.|
Arrhythmias (especially bradycardia), fall in cardiac output leading to hypotension. Increased salivary, gastric and intestinal secretion, nausea, vomiting, increased peristalsis, diarrhea, abdominal cramps.
|Skeletal Muscle:||Weakness, fasciculations.|
|Miscellaneous:||Increased urinary frequency and incontinence, diaphoresis.|
Read the Enlon (edrophonium injection) Side Effects Center for a complete guide to possible side effects
Care should be given when administering this drug to patients with symptoms of myasthenic weakness who are also on anticholinesterase drugs. Since symptoms of anticholinesterase overdose (cholinergic crisis) may mimic underdosage (myasthenic weakness), their condition may be worsened by the use of this drug. (See OVERDOSAGE section for treatment.)
Read the Enlon Drug Interactions Center for a complete guide to possible interactions
Last reviewed on RxList: 1/15/2005
This monograph has been modified to include the generic and brand name in many instances.
Additional Enlon Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.